X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (132) 132
oncology (118) 118
female (108) 108
index medicus (91) 91
aged (72) 72
ovarian cancer (70) 70
middle aged (69) 69
chemotherapy (61) 61
adult (50) 50
cancer (50) 50
ovarian neoplasms - drug therapy (50) 50
carcinoma (41) 41
antineoplastic combined chemotherapy protocols - therapeutic use (40) 40
treatment outcome (33) 33
aged, 80 and over (31) 31
disease-free survival (29) 29
male (29) 29
ovarian neoplasms - pathology (28) 28
prognosis (28) 28
survival (27) 27
hematology, oncology and palliative medicine (25) 25
antineoplastic agents - therapeutic use (23) 23
care and treatment (22) 22
neoplasm staging (22) 22
carboplatin - administration & dosage (21) 21
cisplatin (21) 21
obstetrics & gynecology (21) 21
paclitaxel - administration & dosage (18) 18
research (18) 18
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
bevacizumab (17) 17
pegylated liposomal doxorubicin (17) 17
retrospective studies (16) 16
surgery (16) 16
analysis (15) 15
gastroenterology & hepatology (15) 15
ovarian neoplasms - mortality (15) 15
recurrence (15) 15
tumors (15) 15
carboplatin (14) 14
cervical cancer (14) 14
clinical medicine (14) 14
clinical trials (14) 14
gynecologic-oncology-group (14) 14
immunotherapy (14) 14
time factors (14) 14
disease progression (13) 13
drug therapy (13) 13
expression (13) 13
hematology (13) 13
phase-iii trial (13) 13
therapy (13) 13
doxorubicin - administration & dosage (12) 12
medical and health sciences (12) 12
medicin och hälsovetenskap (12) 12
paclitaxel (12) 12
cancer and oncology (11) 11
cancer och onkologi (11) 11
doxorubicin - analogs & derivatives (11) 11
klinisk medicin (11) 11
patients (11) 11
quality of life (11) 11
radiotherapy (11) 11
women (11) 11
1st-line treatment (10) 10
angiogenesis (10) 10
cancer therapies (10) 10
cell biology (10) 10
combined modality therapy (10) 10
drug administration schedule (10) 10
hepatocellular carcinoma (10) 10
metastasis (10) 10
open-label (10) 10
pharmacology & pharmacy (10) 10
platinum (10) 10
prospective studies (10) 10
survival analysis (10) 10
elderly (9) 9
kaplan-meier estimate (9) 9
oncology, experimental (9) 9
platinum-based chemotherapy (9) 9
polyethylene glycols - administration & dosage (9) 9
randomized-trial (9) 9
stage-iii (9) 9
trial (9) 9
uterine cervical neoplasms - pathology (9) 9
vascular endothelial growth factor (9) 9
cyclophosphamide (8) 8
doxorubicin (8) 8
health aspects (8) 8
italy (8) 8
management (8) 8
neoadjuvant chemotherapy (8) 8
neoplasm recurrence, local - drug therapy (8) 8
neoplasms. tumors. oncology. including cancer and carcinogens (8) 8
oncology-group (8) 8
ovarian neoplasms - genetics (8) 8
ovarian neoplasms - surgery (8) 8
ovarian neoplasms - therapy (8) 8
pharmacology (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 396 - 405
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 78 - 89
Summary Background Angiogenesis is a target in the treatment of ovarian cancer. Nintedanib, an oral triple angiokinase inhibitor of VEGF receptor,... 
Hematology, Oncology and Palliative Medicine | BIBF 1120 | DES CANCERS | INTERGROUP TRIAL | LABEL DOSE-ESCALATION | CISPLATIN | ONCOLOGY | BEVACIZUMAB | TRIPLE ANGIOKINASE INHIBITOR | CARBOPLATIN PLUS PACLITAXEL | III TRIAL | MAINTENANCE THERAPY | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Response Evaluation Criteria in Solid Tumors | Diarrhea - chemically induced | Cytoreduction Surgical Procedures | Indoles - administration & dosage | Young Adult | Peritoneal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Carcinoma - pathology | Neutropenia - chemically induced | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Double-Blind Method | Carcinoma - surgery | Peritoneal Neoplasms - surgery | Anemia - chemically induced | Carboplatin - administration & dosage | Fallopian Tube Neoplasms - pathology | Thrombocytopenia - chemically induced | Disease Progression | Disease-Free Survival | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Fallopian Tube Neoplasms - surgery | Intention to Treat Analysis | Aged | Neoplasm Staging | Ovarian Neoplasms - surgery | Clinical trials | Chemotherapy | Hospitals | Growth factors | Cancer | Ovarian cancer | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1137 - 1146
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 561 - 568
Journal Article
by Pujade-Lauraine, Eric and Ledermann, Jonathan and Ledermann, Jonathan A and Selle, Frédéric and Gebski, Val and Penson, Richard and Penson, Richard T and Oza, Amit M and Oza, Amit and Korach, Jacob and Huzarski, Tomasz and Poveda, Andrés and Pignata, Sandro and Friedlander, Michael and Colombo, Nicoletta and Harter, Philipp and Fujiwara, Keiichi and Ray-Coquard, Isabelle and Banerjee, Susana and Liu, Joyce and Lowe, Elizabeth S and Bloomfield, Ralph and Pautier, Patricia and Byrski, Tomasz and Scambia, Giovanni and Nicoletto, Maria and Nussey, Fiona and Clamp, Andrew and Poveda Velasco, Andrés and Rodrigues, Manuel and Lotz, Jean-Pierre and Provencher, Diane and Prat Aparicio, Aleix and Vidal Boixader, Laura and Scott, Clare and Tamura, Kenji and Yunokawa, Mayu and Lisyanskaya, Alla and Medioni, Jacques and Pécuchet, Nicolas and Dubot, Coraline and de la Motte Rouge, Thibault and Kaminsky, Marie-Christine and Weber, Béatrice and Lortholary, Alain and Parkinson, Christine and Williams, Sarah and Cosin, Jonathan and Hoffman, James and Plante, Marie and Covens, Allan and Sonke, Gabe and Joly, Florence and Floquet, Anne and Hirte, Holger and Amit, Amnon and Park-Simon, Tjoung-Won and Matsumoto, Koji and Tjulandin, Sergei and Kim, Jae Hoon and Kim, Byoung-Gie and Kim, Jae Weon and Gladieff, Laurence and Sabbatini, Roberto and O'Malley, David and Timmins, Patrick and Kredentser, Daniel and Laínez Milagro, Nuria and Barretina Ginesta, Maria Pilar and Tibau Martorell, Ariadna and Gómez de Liaño Lista, Alfonso and Ojeda González, Belén and Mileshkin, Linda and Mandai, Masaki and Boere, Ingrid and Ottevanger, Petronella and Nam, Joo-Hyun and Filho, Elias and Hamizi, Salima and Cognetti, Francesco and Warshal, David and Dickson-Michelson, Elizabeth and Kamelle, Scott and McKenzie, Nathalie and Rodriguez, Gustavo and Armstrong, Deborah and Chalas, Eva and Celano, Paul and Behbakht, Kian and Davidson, Susan and Welch, Stephen and Helpman, Limor and Fishman, Ami and Bruchim, Ilan and Sikorska, Magdalena and Słowińska, Anna and Rogowski, Wojciech and Bidziński, Mariusz and Śpiewankiewicz, Beata and Casado Herraez, Antonio and ... and SOLO2-ENGOT-Ov21 Investigators and SOLO2/ENGOT-Ov21 investigators
The Lancet Oncology, ISSN 1470-2045, 09/2017, Volume 18, Issue 9, pp. 1274 - 1284
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 20, pp. 3323 - 3329
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2019, p. JCO.19.02055
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2013, Volume 110, Issue 24, pp. 9845 - 9850
Epithelial ovarian cancer is the most lethal gynecologic malignancy; it is highly aggressive and causes almost 125,000 deaths yearly. Despite advances in... 
Human umbilical vein endothelial cells | MicroRNA | Carcinoma | Cell lines | Transponders | Signatures | Endothelial cells | Tumors | Ovarian cancer | Cancer | TRIAL | PROFILES | THERAPY | PROGNOSIS | MULTIDISCIPLINARY SCIENCES | EXPRESSION | TUMORS | BREAST | ENDOTHELIAL GROWTH-FACTOR | Paclitaxel - pharmacology | Human Umbilical Vein Endothelial Cells - metabolism | Oligonucleotide Array Sequence Analysis | Neoplasms, Glandular and Epithelial - blood supply | Coculture Techniques | Humans | Gene Expression Regulation, Neoplastic | Gene Expression Profiling | Cystadenocarcinoma, Serous - genetics | Vascular Endothelial Growth Factor Receptor-2 - genetics | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Female | Antineoplastic Agents - pharmacology | Ovarian Neoplasms - blood supply | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Signal Transduction - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Cystadenocarcinoma, Serous - blood supply | Drug Resistance, Neoplasm - genetics | Vascular Endothelial Growth Factor B - metabolism | Carcinoma, Ovarian Epithelial | Cell Line, Tumor | Neovascularization, Pathologic - genetics | Vascular Endothelial Growth Factor B - genetics | MicroRNAs - genetics | Carboplatin - pharmacology | Physiological aspects | Genetic aspects | Neovascularization | Research | Drug therapy | Gene expression | Drug resistance | Health aspects | Biological Sciences
Journal Article
Journal Article
Journal Article
Journal Article